Cite
HARVARD Citation
Hue, J. et al. (2021). Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreatic Adenocarcinoma Treated With Multiagent Neoadjuvant Chemotherapy in the Modern Era. American surgeon. 87 (9), pp. 1386-1395. [Online].